Our goal is to provide you with the clarity you need to stay focused on your long-term metabolic health goals
While demand for GLP-1 drugs appears to be accelerating, uncertainty around affordability, insurance coverage, and long-term access continues to shape whether interest translates into actual treatment
DreamMe is designed for people on GLP-1 medications like Ozempic, Wegovy, Mounjaro, Zepbound, semaglutide, and tirzepatide, or other GLP-1, pills, & peptides
Declarations Funding Funding for this study was received from Eli Lilly and Company
Certain patients should avoid semaglutide, including those with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe pancreatitis
Fermented extracts exhibited increased DPPH and ABTS radical-scavenging capacities and significantly reduced nitric oxide production from day six of fermentation